Tetra Radar · Company Timeline

Celcuity Inc (CELC)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved Revtorpyk in combination with fulvestran, to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer without a PIK3CA mutation detected following progression on or after treatment with at l…

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.